Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
79
天
ABL209 (NEOK002): Designing an EGFR × MUC1 Bispecific TOP1i ADC with Promising Antitumor Activity and Enhanced Therapeutic Window
作者
Bora Lee; Hyeon Ji Park; Byeong Min Yoo; Hangil Kim; Arim Seo; Youngeun Hong; Yo-Seob Lee; Donghoon Yeom; Yong-Gyu Son; Jaehyun Eom; Daehae Song; Byungje Sung; Jinhyung Ahn; Junyoung Kim; Weon-Kyoo You; Sang Hoon Lee; Jinwon Jung展开收起
作者单位
1. https://ror.org/01e0hcx30ABL Bio Inc., Seoul, Republic of Korea.展开收起
86
天
An Integrin β6–Targeted Antibody–Drug Conjugate Optimized for Intravesical Delivery to Treat Non–Muscle-Invasive Bladder Cancer
作者
Christopher M. Carosino; Devra J. Olson; Rebecca C. Mazahreh; David J. Ortiz; Steve Duniho; Eliana Moskovitz; Marlena Gray; Renee F. Hein; Nicolas H. Garcia; Hamidreza Ardalani; Lauren Farr; Tianyang Yan; Maddy Burcher; Iliyana Mikell; Matthew R. Levengood; Sharsti Sandall; Joseph D. Dekker展开收起
作者单位
1. Pfizer, Inc., Bothell, Washington.展开收起
256
天
JNJ-79032421, a Novel Membrane-Restricted Mesothelin-Targeting T Cell–Engaging Bispecific Antibody for the Treatment of Mesothelin-Positive Cancers
作者
Karine Smans; Thomas Nesspor; Sabine De Breucker; Erika van Heerde; Annemie Valckx; Nele Van Slycken; Katrin Sproesser; Bethany Mattson Cypert; Kathryn Packman; Gerald Chu; Jamie Fisher; Nicholas Mazzanti; Ted Petley; Winnie Chan; Brian Del Rosario; Tun Liu; Stuart Ember; Paul L. Shaffer; Jacalyn S. Clawson; Joshua M. Bauml; Sheri Moores; Sylvie Laquerre; Paul R. Gavine展开收起
作者单位
1. Oncology, Johnson & Johnson, Beerse, Belgium.; 2. Therapeutics Discovery, https://ror.org/03qd7mz70Johnson & Johnson, Springhouse, Pennsylvania.; 3. Oncology, https://ror.org/03qd7mz70Johnson & Johnson, Springhouse, Pennsylvania.; 4. Oncology, https://ror.org/03qd7mz70Johnson & Johnson, Cambridge, Massachusetts.展开收起
234
天
Microsatellite Instable Cancer Cells Acquire On-target Resistance Mutations to WRN Helicase Inhibitors
作者
Faith Fowler; Jessica Gajda; Amirhossein Mafi; Aileen Kelly; Cynthia L. Jeffries; Phuong Le; Lei Shi; Mariam George; Nathaniel Elsen; Alla V. Korepanova; Sarah M. Zerbs; Orville A. Pemberton; Xiangdong Xu; Nathan Gesmundo; Wei Qiu; Fei Han; Henry Tang; Sanjay C. Panchal; Michael Dart; Jonathan Hickson; Chaohong Sun; Yunsong Tong; Ari J. Firestone展开收起
作者单位
1. Calico Life Sciences LLC, South San Francisco, California.; 2. https://ror.org/02g5p4n58AbbVie (United States), North Chicago, Illinois.展开收起
174
天
NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors
作者
Theodore T. Nguyen; Nitesh K. Nandwana; Yellamelli V.V. Srikanth; Tetyana Bagnyukova; Oleksandra Chkhalo; Kathy Q. Cai; Julia Lamperelli; Shabnam Pirestani; Manish Kumar Mehra; Barbara A. Burtness; Hossein Borghaei; Ravikumar Akunuri; Joel Cassel; Lily Lu; Joseph M. Salvino; Erica A. Golemis展开收起
作者单位
1. https://ror.org/0567t7073Fox Chase Cancer Center, Philadelphia, Pennsylvania.; 2. Drexel University College of Medicine, Philadelphia, Pennsylvania.; 3. Medicinal Chemistry and Molecular and Cellular Oncogenesis Program, https://ror.org/04wncat98The Wistar Institute, Philadelphia, Pennsylvania.; 4. Pharmaceutical Faculty, Bogomolets National Medical University, Kyiv, Ukraine.; 5. Section of Medical Oncology, Department of Internal Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.; 6. Molecular Screening Shared Resource, https://ror.org/04wncat98The Wistar Institute, Philadelphia, Pennsylvania.; 7. Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, Pennsylvania.展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天